GLOBAL RADIOPHARMACEUTICAL (ORAL ROUTE) MARKET 2022 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

May 2022 119
Table of Contents

1 Market Overview
1.1 Radiopharmaceutical (Oral Route) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceutical (Oral Route) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceutical (Oral Route) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical (Oral Route) Market Size & Forecast
1.4.1 Global Radiopharmaceutical (Oral Route) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Radiopharmaceutical (Oral Route) Sales in Volume (2017-2028)
1.4.3 Global Radiopharmaceutical (Oral Route) Price (2017-2028)
1.5 Global Radiopharmaceutical (Oral Route) Production Capacity Analysis
1.5.1 Global Radiopharmaceutical (Oral Route) Total Production Capacity (2017-2028)
1.5.2 Global Radiopharmaceutical (Oral Route) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Radiopharmaceutical (Oral Route) Market Drivers
1.6.2 Radiopharmaceutical (Oral Route) Market Restraints
1.6.3 Radiopharmaceutical (Oral Route) Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Radiopharmaceutical (Oral Route) Product and Services
2.1.4 Bracco Imaging Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Radiopharmaceutical (Oral Route) Product and Services
2.2.4 Bayer Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Radiopharmaceutical (Oral Route) Product and Services
2.3.4 Mallinckrodt Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Radiopharmaceutical (Oral Route) Product and Services
2.4.4 Nordion Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Radiopharmaceutical (Oral Route) Product and Services
2.5.4 Triad Isotopes Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Radiopharmaceutical (Oral Route) Product and Services
2.6.4 Lantheus Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 IBA Group
2.7.1 IBA Group Details
2.7.2 IBA Group Major Business
2.7.3 IBA Group Radiopharmaceutical (Oral Route) Product and Services
2.7.4 IBA Group Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Radiopharmaceutical (Oral Route) Product and Services
2.8.4 GE Healthcare Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 China Isotope & Radiation
2.9.1 China Isotope & Radiation Details
2.9.2 China Isotope & Radiation Major Business
2.9.3 China Isotope & Radiation Radiopharmaceutical (Oral Route) Product and Services
2.9.4 China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Radiopharmaceutical (Oral Route) Product and Services
2.10.4 Jubilant Pharma Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Radiopharmaceutical (Oral Route) Product and Services
2.11.4 Eli Lilly Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Advanced Accelerator Applications
2.12.1 Advanced Accelerator Applications Details
2.12.2 Advanced Accelerator Applications Major Business
2.12.3 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product and Services
2.12.4 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business
2.13.3 SIEMENS Radiopharmaceutical (Oral Route) Product and Services
2.13.4 SIEMENS Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Radiopharmaceutical (Oral Route) Product and Services
2.14.4 Dongcheng Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Navidea
2.15.1 Navidea Details
2.15.2 Navidea Major Business
2.15.3 Navidea Radiopharmaceutical (Oral Route) Product and Services
2.15.4 Navidea Radiopharmaceutical (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Radiopharmaceutical (Oral Route) Breakdown Data by Manufacturer
3.1 Global Radiopharmaceutical (Oral Route) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Radiopharmaceutical (Oral Route) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Radiopharmaceutical (Oral Route)
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceutical (Oral Route) Manufacturer Market Share in 2021
3.4.2 Top 6 Radiopharmaceutical (Oral Route) Manufacturer Market Share in 2021
3.5 Global Radiopharmaceutical (Oral Route) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Radiopharmaceutical (Oral Route) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Radiopharmaceutical (Oral Route) Market Size by Region
4.1.1 Global Radiopharmaceutical (Oral Route) Sales in Volume by Region (2017-2028)
4.1.2 Global Radiopharmaceutical (Oral Route) Revenue by Region (2017-2028)
4.2 North America Radiopharmaceutical (Oral Route) Revenue (2017-2028)
4.3 Europe Radiopharmaceutical (Oral Route) Revenue (2017-2028)
4.4 Asia-Pacific Radiopharmaceutical (Oral Route) Revenue (2017-2028)
4.5 South America Radiopharmaceutical (Oral Route) Revenue (2017-2028)
4.6 Middle East and Africa Radiopharmaceutical (Oral Route) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Radiopharmaceutical (Oral Route) Sales in Volume by Type (2017-2028)
5.2 Global Radiopharmaceutical (Oral Route) Revenue by Type (2017-2028)
5.3 Global Radiopharmaceutical (Oral Route) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Radiopharmaceutical (Oral Route) Sales in Volume by Application (2017-2028)
6.2 Global Radiopharmaceutical (Oral Route) Revenue by Application (2017-2028)
6.3 Global Radiopharmaceutical (Oral Route) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Radiopharmaceutical (Oral Route) Sales by Type (2017-2028)
7.2 North America Radiopharmaceutical (Oral Route) Sales by Application (2017-2028)
7.3 North America Radiopharmaceutical (Oral Route) Market Size by Country
7.3.1 North America Radiopharmaceutical (Oral Route) Sales in Volume by Country (2017-2028)
7.3.2 North America Radiopharmaceutical (Oral Route) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Radiopharmaceutical (Oral Route) Sales by Type (2017-2028)
8.2 Europe Radiopharmaceutical (Oral Route) Sales by Application (2017-2028)
8.3 Europe Radiopharmaceutical (Oral Route) Market Size by Country
8.3.1 Europe Radiopharmaceutical (Oral Route) Sales in Volume by Country (2017-2028)
8.3.2 Europe Radiopharmaceutical (Oral Route) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Type (2017-2028)
9.2 Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Application (2017-2028)
9.3 Asia-Pacific Radiopharmaceutical (Oral Route) Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceutical (Oral Route) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Radiopharmaceutical (Oral Route) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Radiopharmaceutical (Oral Route) Sales by Type (2017-2028)
10.2 South America Radiopharmaceutical (Oral Route) Sales by Application (2017-2028)
10.3 South America Radiopharmaceutical (Oral Route) Market Size by Country
10.3.1 South America Radiopharmaceutical (Oral Route) Sales in Volume by Country (2017-2028)
10.3.2 South America Radiopharmaceutical (Oral Route) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type (2017-2028)
11.2 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application (2017-2028)
11.3 Middle East & Africa Radiopharmaceutical (Oral Route) Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceutical (Oral Route) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Radiopharmaceutical (Oral Route) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Radiopharmaceutical (Oral Route)
12.3 Radiopharmaceutical (Oral Route) Production Process
12.4 Radiopharmaceutical (Oral Route) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Radiopharmaceutical (Oral Route) Typical Distributors
13.3 Radiopharmaceutical (Oral Route) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Radiopharmaceutical (Oral Route) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Radiopharmaceutical (Oral Route) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Radiopharmaceutical (Oral Route) Product and Services
Table 6. Bracco Imaging Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Radiopharmaceutical (Oral Route) Product and Services
Table 10. Bayer Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Radiopharmaceutical (Oral Route) Product and Services
Table 14. Mallinckrodt Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Nordion Basic Information, Manufacturing Base and Competitors
Table 16. Nordion Major Business
Table 17. Nordion Radiopharmaceutical (Oral Route) Product and Services
Table 18. Nordion Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 20. Triad Isotopes Major Business
Table 21. Triad Isotopes Radiopharmaceutical (Oral Route) Product and Services
Table 22. Triad Isotopes Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Lantheus Basic Information, Manufacturing Base and Competitors
Table 24. Lantheus Major Business
Table 25. Lantheus Radiopharmaceutical (Oral Route) Product and Services
Table 26. Lantheus Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. IBA Group Basic Information, Manufacturing Base and Competitors
Table 28. IBA Group Major Business
Table 29. IBA Group Radiopharmaceutical (Oral Route) Product and Services
Table 30. IBA Group Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. GE Healthcare Major Business
Table 33. GE Healthcare Radiopharmaceutical (Oral Route) Product and Services
Table 34. GE Healthcare Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 36. China Isotope & Radiation Major Business
Table 37. China Isotope & Radiation Radiopharmaceutical (Oral Route) Product and Services
Table 38. China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Jubilant Pharma Major Business
Table 41. Jubilant Pharma Radiopharmaceutical (Oral Route) Product and Services
Table 42. Jubilant Pharma Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Radiopharmaceutical (Oral Route) Product and Services
Table 46. Eli Lilly Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 48. Advanced Accelerator Applications Major Business
Table 49. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product and Services
Table 50. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 52. SIEMENS Major Business
Table 53. SIEMENS Radiopharmaceutical (Oral Route) Product and Services
Table 54. SIEMENS Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 56. Dongcheng Major Business
Table 57. Dongcheng Radiopharmaceutical (Oral Route) Product and Services
Table 58. Dongcheng Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Navidea Basic Information, Manufacturing Base and Competitors
Table 60. Navidea Major Business
Table 61. Navidea Radiopharmaceutical (Oral Route) Product and Services
Table 62. Navidea Radiopharmaceutical (Oral Route) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Radiopharmaceutical (Oral Route) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Radiopharmaceutical (Oral Route) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Radiopharmaceutical (Oral Route), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Radiopharmaceutical (Oral Route) Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Radiopharmaceutical (Oral Route) Production Site of Key Manufacturer
Table 68. Radiopharmaceutical (Oral Route) New Entrant and Capacity Expansion Plans
Table 69. Radiopharmaceutical (Oral Route) Mergers & Acquisitions in the Past Five Years
Table 70. Global Radiopharmaceutical (Oral Route) Sales by Region (2017-2022) & (K Units)
Table 71. Global Radiopharmaceutical (Oral Route) Sales by Region (2023-2028) & (K Units)
Table 72. Global Radiopharmaceutical (Oral Route) Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Radiopharmaceutical (Oral Route) Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 75. Global Radiopharmaceutical (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 76. Global Radiopharmaceutical (Oral Route) Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Radiopharmaceutical (Oral Route) Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Radiopharmaceutical (Oral Route) Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Radiopharmaceutical (Oral Route) Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 81. Global Radiopharmaceutical (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 82. Global Radiopharmaceutical (Oral Route) Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Radiopharmaceutical (Oral Route) Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Radiopharmaceutical (Oral Route) Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Radiopharmaceutical (Oral Route) Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Radiopharmaceutical (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 87. North America Radiopharmaceutical (Oral Route) Sales by Country (2023-2028) & (K Units)
Table 88. North America Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Radiopharmaceutical (Oral Route) Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 91. North America Radiopharmaceutical (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 92. North America Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 93. North America Radiopharmaceutical (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 94. Europe Radiopharmaceutical (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 95. Europe Radiopharmaceutical (Oral Route) Sales by Country (2023-2028) & (K Units)
Table 96. Europe Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Radiopharmaceutical (Oral Route) Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 99. Europe Radiopharmaceutical (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 100. Europe Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 101. Europe Radiopharmaceutical (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Radiopharmaceutical (Oral Route) Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Radiopharmaceutical (Oral Route) Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 110. South America Radiopharmaceutical (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 111. South America Radiopharmaceutical (Oral Route) Sales by Country (2023-2028) & (K Units)
Table 112. South America Radiopharmaceutical (Oral Route) Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Radiopharmaceutical (Oral Route) Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 115. South America Radiopharmaceutical (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 116. South America Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 117. South America Radiopharmaceutical (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 126. Radiopharmaceutical (Oral Route) Raw Material
Table 127. Key Manufacturers of Radiopharmaceutical (Oral Route) Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Radiopharmaceutical (Oral Route) Typical Distributors
Table 131. Radiopharmaceutical (Oral Route) Typical Customers
List of Figures
Figure 1. Radiopharmaceutical (Oral Route) Picture
Figure 2. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Type in 2021
Figure 3. Actinium-225
Figure 4. Lutetium-177
Figure 5. Radium-223
Figure 6. Holmium-166
Figure 7. Other
Figure 8. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Application in 2021
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Global Radiopharmaceutical (Oral Route) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Radiopharmaceutical (Oral Route) Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Radiopharmaceutical (Oral Route) Sales (2017-2028) & (K Units)
Figure 15. Global Radiopharmaceutical (Oral Route) Price (2017-2028) & (US$/Unit)
Figure 16. Global Radiopharmaceutical (Oral Route) Production Capacity (2017-2028) & (K Units)
Figure 17. Global Radiopharmaceutical (Oral Route) Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Radiopharmaceutical (Oral Route) Market Drivers
Figure 19. Radiopharmaceutical (Oral Route) Market Restraints
Figure 20. Radiopharmaceutical (Oral Route) Market Trends
Figure 21. Global Radiopharmaceutical (Oral Route) Sales Market Share by Manufacturer in 2021
Figure 22. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Manufacturer in 2021
Figure 23. Radiopharmaceutical (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Radiopharmaceutical (Oral Route) Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Radiopharmaceutical (Oral Route) Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Radiopharmaceutical (Oral Route) Sales Market Share by Region (2017-2028)
Figure 27. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Region (2017-2028)
Figure 28. North America Radiopharmaceutical (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 29. Europe Radiopharmaceutical (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Radiopharmaceutical (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 31. South America Radiopharmaceutical (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 33. Global Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2028)
Figure 34. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Type (2017-2028)
Figure 35. Global Radiopharmaceutical (Oral Route) Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2028)
Figure 37. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Application (2017-2028)
Figure 38. Global Radiopharmaceutical (Oral Route) Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2028)
Figure 40. North America Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2028)
Figure 41. North America Radiopharmaceutical (Oral Route) Sales Market Share by Country (2017-2028)
Figure 42. North America Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2017-2028)
Figure 43. United States Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2028)
Figure 47. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2028)
Figure 48. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Country (2017-2028)
Figure 49. Europe Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2017-2028)
Figure 50. Germany Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Radiopharmaceutical (Oral Route) Revenue Market Share by Region (2017-2028)
Figure 59. China Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2028)
Figure 66. South America Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2028)
Figure 67. South America Radiopharmaceutical (Oral Route) Sales Market Share by Country (2017-2028)
Figure 68. South America Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Radiopharmaceutical (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Market Share by

Table of Contents

Related reports :

(Sep 22)

This report describes the global market size of In-Vitro Diagnostics Packaging from 2017 to 2021 and its CAGR from 2017 to 2021, and also fo...

(Sep 22)

This report describes the global market size of Hospital Acquired Infection Treatment from 2017 to 2021 and its CAGR from 2017 to 2021, and ...

(Sep 22)

This report describes the global market size of H7N9 Vaccine from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market...

(Sep 22)

This report describes the global market size of Green & Bio-based Solvents from 2017 to 2021 and its CAGR from 2017 to 2021, and also foreca...

(Sep 22)

This report describes the global market size of Islet Amyloid Polypeptide from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecas...

(Sep 22)

This report describes the global market size of HPLC Accessory from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its mark...

Global Info Research

GLOBAL RADIOPHARMACEUTICAL (ORAL ROUTE) MARKET 2022 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy